Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Pepgen logo in colour

PepGen has been awarded a significant grant from Innovate UK, the UK’s innovation agency, to support the development and validation of the company’s peptide-mediated delivery technology. The project is entitled “Application of a novel peptide delivery platform to nucleic acid therapeutics in degenerative and rare diseases”, and will support PepGen’s work in this area over a 20-month period. The grant, awarded as part of the highly competitive Biomedical Catalyst programme, provides the company with £1.6M in funding, and commenced on the 1st of February 2019.